Changes in the clinical and epidemiological features of group A streptococcal bacteraemia in Australia's northern territory

Tropical Medicine and International Health

Volumn 20, Issue 1, 2015, Pages 40-47

  Gear, R J ^a   Carter, J C ^a   Carapetis, J R ^a,b,c   Baird, R ^a   Davis, J S ^a,c  

^a ROYAL DARWIN HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

Australia; Bacteraemia; Group A streptococcus; Indigenous; Northern Territory; Tropical

Indexed keywords

CLINDAMYCIN; LINCOMYCIN;

ADULT; ARTICLE; AUSTRALIA; BLOOD CULTURE; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; GROUP A STREPTOCOCCAL INFECTION; HOSPITAL LABORATORY; HUMAN; INCIDENCE; INDIGENOUS AUSTRALIAN; INJURY; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PYODERMA; SCABIES; TOXIC SHOCK SYNDROME; ADOLESCENT; AGED; CHILD; MIDDLE AGED; OCEANIC ANCESTRY GROUP; PRESCHOOL CHILD; RISK FACTOR; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; YOUNG ADULT;

STREPTOCOCCUS SP. 'GROUP A';

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NORTHERN TERRITORY; OCEANIC ANCESTRY GROUP; RISK FACTORS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; YOUNG ADULT;

EID: 84913618581     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12405     Document Type: Article

References (40)

1. ANZDATA (2007) Australian and New Zealand Dialysis and Transplant Registry Annual Report 2007. ANZDATA, Adelaide.
2. Australian Bureau of Statistics (2007, 2012) Northern Territory from 2006 and 2011 Census of Population and Housing. ABS, Canberra.
3. Berkley JA, Lowe BS, Mwangi I et al. (2005) Bacteremia among children admitted to a rural hospital in Kenya. New England Journal of Medicine 352, 39-47.
4. Bone RC, Balk RA, Cerra FB et al. (1992) Definitions for sepsis and organ failure and guidelines for the innovative use of therapies in sepsis. Chest 101, 1644-1655.
5. Carapetis JR & Currie BJ (1997) Clinical epidemiology of rheumatic fever and rheumatic heart disease in tropical Australia. Advances in Experimental Medicine and Biology 419, 233-236.
6. Carapetis JR, Robins-Brown R, Martin D, Shelby-James T & Hogg G (1995) Increasing severity of invasive group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-non-typeable clone. Clinical Infectious Diseases 21, 1220-1227.
7. Carapetis JR, Wolff DR & Currie BJ (1996) Acute rheumatic fever and rheumatic heart disease in the Top End of Australia's Northern Territory. Medical Journal of Australia 164, 146-149.
8. Carapetis JR, Connors C, Yarmirr D, Krause V & Currie BJ (1997) Success of a scabies control program in an Australian aboriginal community. The Pediatric Infectious Disease Journal 16, 494-499.
9. Carapetis JR, Currie BJ & Kaplan EL (1999a) Epidemiology and prevention of group A streptococcal infections: acute respiratory tract infections, skin infections, and their sequelae at the close of the twentieth century. Clinical Infectious Diseases 28, 205-210.
10. Carapetis JR, Walker AM, Hibble M, Sriprakash S & Currie BJ (1999b) Clinical and epidemiological features of group A streptococcal bacteremia in a region with hyperendemic superficial streptococcal infection. Epidemiology & Infection 122, 59-65.
11. Carapetis JR, Steer AC, Mullholland EK & Weber M (2005) The global burden of group A streptococcal diseases. Lancet 5, 685-694.
12. Darenberg J, Ihendyane N, Sjölin J et al. (2003) Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clinical Infectious Diseases 37, 333-340.
13. Davis JS, Cheng AC, McMillan M, Humphrey AB, Stephens DP & Anstey N (2011) Sepsis in the tropical Top End of Australia's Northern Territory: disease burden and impact on Indigenous Australians. Medical Journal of Australia 194, 519-524.
14. Gastanaduy AS, Kaplan EL, Huwe BB, McKay C & Wannamaker LW (1980) Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis. Lancet 2, 498.
15. Gracey M & King M (2009) Indigenous health part 1: determinants and disease patterns. Lancet 374, 65-75.
16. Hoen B, Paul-Dauphin A, Hestin D & Kessler M (1998) EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. Journal of the American Society of Nephrology 9, 869-876.
17. Hoge CW, Schwartz B, Talkington D, Breiman RF, MacNeill EM & Englender SJ (1993) The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome: a retrospective population-based study. Journal of the American Medical Association 269, 384-389.
18. Imohl M, Reinert RR, Ocklenburg C & van der Linden M (2010) Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003-2007. FEMS Immunology and Medical Microbiology 58, 389-396.
19. Keyfitz N (1966) Sampling variance of standardized mortality rates. Human Biology 38, 309-317.
20. Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A et al. (2008) Epidemiology of severe Streptococcus pyogenes disease in Europe. Journal of Clinical Microbiology 46, 2359-2367.
21. McDonald MI, Towers RJ, Andrews RM, Benger N, Currie B & Carapetis JR (2006) Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic. Clinical Infectious Diseases 43, 683-689.
22. Montes M, Ardanuy C, Tamayo E, Domenech A, Linares J & Perez-Trallero E (2011) Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998-2009): comparison with non-invasive isolates. European Journal of Clinical Microbiology & Infectious Diseases 30, 1295-1302.
23. Norton R, Smith HV, Wood N, Siegbrecht E, Ross A & Ketheesan N (2004) Invasive group A streptococcal disease in North Queensland (1996-2001). Indian Journal of Medical Research 119, 148-151.
24. O'Grady KF, Kelpie L, Andrews RM et al. (2007) The epidemiology of invasive group A streptococcal disease in Victoria, Australia. Medical Journal of Australia 186, 565-569.
25. Plainvert C, Doloy A, Loubinoux J et al. (2012) Invasive group A streptococcal infections in adults, France (2006-2010). Clinical Microbiology and Infection 18, 702-710.
26. Steer AC, Jenney AJ, Oppedisano F et al. (2008) High burden of invasive b-haemolytic streptococcal infections in Fiji. Epidemiology and Infection 136, 621-627.
27. Steer AC, Jenney A, Kado J et al. (2009a) Prospective surveillance of invasive group A streptococcal disease, Fiji, 2005-2007. Emerging Infectious Diseases 15, 215-222.
28. Steer AC, Law I, Matatolu L, Beall BW & Carapetis JR (2009b) Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet 9, 611-616.
29. Steer AC, Lamagni T, Curtis N & Carapetis JR (2012) Invasive group A streptococcal disease. Drugs 72, 1213-1227.
30. Stevens DL (2001) Invasive streptococcal infections. Journal of Infection and Chemotherapy 7, 69-80.
31. Stevens DL, Gibbons AE, Bergstrom R & Winn V (1988) The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. Journal of Infectious Diseases 158, 23.
32. Stevens DL, Sexton DJ & Baron EL (2011) Group A streptococcal (Streptococcus pyogenes) bacteremia in adults. Up To Date. www.uptodate.com. Accessed 24 February 2013.
33. Streeton CL, Hanna JN, Messer RD & Merianos A (1995) An epidemic of acute post-streptococcal glomerulonephritis among aboriginal children. Journal of Paediatrics and Child Health 31, 245-248.
34. Torzillo PJ, Pholeros P, Rainow S et al. (2008) The state of health hardware in aboriginal communities in rural and remote Australia. Australian and New Zealand Journal of Public Health 32, 7-11.
35. Vincent JL, Moreno R, Takala J et al. (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Medicine 7, 707-710.
36. Whitehead BD, Smith HV & Nourse C (2011) Invasive group A streptococcal disease in children in Queensland. Epidemiology and Infection 139, 623-628.
37. Working Group on Severe Streptococcal Infections (1993) Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. Journal of the American Medical Association 269, 390.
38. World Health Organization (2004) The World Health Report 2004. WHO, Geneva.
39. Zakikhany K, Degail MA, Lamagni T et al. (2011) Increase in invasive Streptococcus pyogenes and Streptococcus pneumonia infections in England, December 2010 to January 2011. Euro Surveillance 16, 6-9.
40. Zimbelman J, Palmer A & Todd J (1999) Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. The Pediatric Infectious Disease Journal 18, 1096.